NewsBenzingaTrascrizione della conference call sui risultati del secondo trimestre 2026 di Amylyx Pharma Trascrizione della conference call sui risultati del secondo trimestre 2026 di Amylyx Pharma Benzinga 2026.10.05 11:25 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Overweight on Coca-Cola Europacific, Lowers Price Target to $115 GameStop CEO Ryan Cohen Keeps Buying: Two New Filings in One Week Wells Fargo Maintains Overweight on Anheuser-Busch InBev, Lowers Price Target to $88 Highest Yielding Hyperscaler Bonds in October 2026: SpaceX Joins Oracle Above 7.5% NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M Maris-Tech Receives Pilot Order For Armored Vehicle Situational Awareness Application
NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M
